Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Transdermal And Transmucosal Drug Delivery market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 7.5% during the forecast period.
This report presents the market size and development trends by detailing the Transdermal And Transmucosal Drug Delivery market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Transdermal And Transmucosal Drug Delivery market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Transdermal And Transmucosal Drug Delivery industry and will help you to build a panoramic view of the industrial development.
Transdermal And Transmucosal Drug Delivery Market, By Type:
Type 1
Type 2
Type 3
Transdermal And Transmucosal Drug Delivery Market, By Application:
End-User 1
End-User 2
End-User 3
Some of the leading players are as follows:
Apricus BioSciences, Inc
Antares Pharma, Inc
Inovio Pharmaceuticals, Inc
Noven Pharmaceuticals, Inc
Corium International, Inc
Aveva Drug Delivery Systems.
Nitto Denko Corporation.
Generex Biotechnology Corporation.
MedPharm LTD
Lohmann Therapy-Systems Corp.
ALZA Corporation
Nemaura Pharma Ltd.
DURECT Corporation
Acrux Limited
Pantec Biosolutions AG
Mylan, Inc.
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Transdermal And Transmucosal Drug Delivery Market: Technology Type Analysis
-
4.1 Transdermal And Transmucosal Drug Delivery Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Transdermal And Transmucosal Drug Delivery Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Type 1
4.3.2 Type 2
4.3.3 Type 3
5 Transdermal And Transmucosal Drug Delivery Market: Product Analysis
-
5.1 Transdermal And Transmucosal Drug Delivery Product Market Share Analysis, 2018 & 2026
-
5.2 Transdermal And Transmucosal Drug Delivery Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Transdermal And Transmucosal Drug Delivery Market: Application Analysis
-
6.1 Transdermal And Transmucosal Drug Delivery Application Market Share Analysis, 2018 & 2026
-
6.2 Transdermal And Transmucosal Drug Delivery Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 End-User 1
6.3.2 End-User 1
6.3.3 End-User 3
7 Transdermal And Transmucosal Drug Delivery Market: Regional Analysis
-
7.1 Transdermal And Transmucosal Drug Delivery Regional Market Share Analysis, 2018 & 2026
-
7.2 Transdermal And Transmucosal Drug Delivery Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Apricus BioSciences, Inc
9.1.1 Apricus BioSciences, Inc Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Antares Pharma, Inc
9.2.1 Antares Pharma, Inc Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Inovio Pharmaceuticals, Inc
9.3.1 Inovio Pharmaceuticals, Inc Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Noven Pharmaceuticals, Inc
9.4.1 Noven Pharmaceuticals, Inc Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Corium International, Inc
9.5.1 Corium International, Inc Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Aveva Drug Delivery Systems.
9.6.1 Aveva Drug Delivery Systems. Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Nitto Denko Corporation.
9.7.1 Nitto Denko Corporation. Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Generex Biotechnology Corporation.
9.8.1 Generex Biotechnology Corporation. Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 MedPharm LTD
9.9.1 MedPharm LTD Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Lohmann Therapy-Systems Corp.
9.10.1 Lohmann Therapy-Systems Corp. Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 ALZA Corporation
9.11.1 ALZA Corporation Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Nemaura Pharma Ltd.
9.12.1 Nemaura Pharma Ltd. Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 DURECT Corporation
9.13.1 DURECT Corporation Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Acrux Limited
9.14.1 Acrux Limited Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 Pantec Biosolutions AG
9.15.1 Pantec Biosolutions AG Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
9.16 Mylan, Inc.
9.16.1 Mylan, Inc. Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis
The List of Tables and Figures (Totals 61 Figures and 135 Tables)
Figure Type 1 Transdermal And Transmucosal Drug Delivery market, 2015 - 2026 (USD Million)
Figure Type 2 Transdermal And Transmucosal Drug Delivery market, 2015 - 2026 (USD Million)
Figure Type 3 Transdermal And Transmucosal Drug Delivery market, 2015 - 2026 (USD Million)
Figure End-User 1 market, 2015 - 2026 (USD Million)
Figure End-User 2 market, 2015 - 2026 (USD Million)
Figure End-User 3 market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Transdermal And Transmucosal Drug Delivery market, by country, 2015 - 2026 (USD Million)
-
Table North America Transdermal And Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table North America Transdermal And Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table North America Transdermal And Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Transdermal And Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Transdermal And Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Transdermal And Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Transdermal And Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Canada Transdermal And Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Canada Transdermal And Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Europe Transdermal And Transmucosal Drug Delivery market, by country, 2015 - 2026 (USD Million)
-
Table Europe Transdermal And Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Europe Transdermal And Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Europe Transdermal And Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Transdermal And Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Transdermal And Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Transdermal And Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Transdermal And Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Germany Transdermal And Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Germany Transdermal And Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Transdermal And Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table France Transdermal And Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table France Transdermal And Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Transdermal And Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Italy Transdermal And Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Italy Transdermal And Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Transdermal And Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Spain Transdermal And Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Spain Transdermal And Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Transdermal And Transmucosal Drug Delivery market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Transdermal And Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Transdermal And Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Transdermal And Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Transdermal And Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table China Transdermal And Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table China Transdermal And Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Transdermal And Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Japan Transdermal And Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Japan Transdermal And Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Transdermal And Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table India Transdermal And Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table India Transdermal And Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Transdermal And Transmucosal Drug Delivery market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Transdermal And Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Transdermal And Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Transdermal And Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Transdermal And Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Transdermal And Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Transdermal And Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Transdermal And Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Transdermal And Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Transdermal And Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Transdermal And Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Transdermal And Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Transdermal And Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table MEA Transdermal And Transmucosal Drug Delivery market, by country, 2015 - 2026 (USD Million)
-
Table MEA Transdermal And Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table MEA Transdermal And Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table MEA Transdermal And Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Transdermal And Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Transdermal And Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Transdermal And Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Transdermal And Transmucosal Drug Delivery market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Transdermal And Transmucosal Drug Delivery market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Transdermal And Transmucosal Drug Delivery market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Apricus BioSciences, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Antares Pharma, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Inovio Pharmaceuticals, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Noven Pharmaceuticals, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Corium International, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Aveva Drug Delivery Systems. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Nitto Denko Corporation. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Generex Biotechnology Corporation. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table MedPharm LTD Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Lohmann Therapy-Systems Corp. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table ALZA Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Nemaura Pharma Ltd. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table DURECT Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Acrux Limited Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pantec Biosolutions AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mylan, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
